Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type ...

To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from ...

Kanazawa University, report in Nature Communications on how the targeted suppression of lysosome function may lead to brain ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled “Imipridones ONC201/ONC206 + RT/TMZ ...

A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.

Love, who represented Utah, had been battling glioblastoma, a malignant brain tumor. She had received immunotherapy treatment as part of a clinical trial, but her daughter revealed earlier this month ...